Buy Tagrisso (osimertinib)

What is Tagrisso (osimertinib) for?

Buy Tagrisso (osimertinib). Tagrisso (osimertinib) is a drug used to treat lung cancer. It works for patients with a specific mutation in the EGFR gene. This mutation is found in non-small cell lung cancer (NSCLC).

• It’s used as a first-line treatment for those with EGFR exon 19 deletions or exon 21 L858R mutations.
• It’s also a second-line treatment for those whose lung cancer has grown after other treatments.

Tagrisso comes in tablets of 40mg or 80mg osimertinib mesylate.

How does Tagrisso (osimertinib) work?

The EGFR gene controls cell growth and division. In lung cancer, this gene is often too active. Tagrisso targets this gene to slow down cancer cell growth.

Unlike other treatments, Tagrisso works on cancer cells with the T790M mutation. This makes it a powerful tool against lung cancer.

Where has Tagrisso (osimertinib) been approved?

Tagrisso has been approved in many places for treating lung cancer. It’s approved for patients with the EGFR T790M mutation. Here are some places where it’s approved:

• Food and Drug Administration (FDA), USA:
  • November 13, 2015, with accelerated approval (second-line treatment)
  • March 30, 2017, with regular approval (second-line treatment)
  • April 18, 2018, as a first line treatment
• European Medical Agency (EMA), European Union:
  • February 2, 2016 (second-line treatment)
  • June 11, 2018 (first-line treatment)
• Health Canada, July 19, 2016 (first- and second-line treatment)
• Therapeutic Goods Administration (TGA), Australia, August 3, 2016 (second-line treatment)
• Medsafe (New Zealand), October 5, 2017 (first-line treatment)

This medicine might also be approved in other places. If you have questions, our support team can help.

We’ve helped patients from many countries get Tagrisso. Most of our patients are from:

• India
• United Kingdom
• Pakistan
• Malaysia
• Philippines
• Bangladesh

How is Tagrisso (osimertinib) taken?

The usual dose is:

• 80 mg tablets orally once daily

If side effects happen, the dose might be lowered to 40 mg once daily. Or treatment might be paused or stopped.

The prices of 40mg and 80mg tablets are similar. This is to make treatment costs the same for all patients, whether they need a low or high dose.

For more details on dosage and how to take Tagrisso, see the official prescribing information in our resources section.

Note: Always talk to your doctor about the right dose for you.

Are there any known side effects or adverse reactions of Tagrisso (osimertinib)?

Common adverse reactions

The most common side effects of Tagrisso include:

• diarrhoea
• rash
• dry skin
• nail toxicity
• fatigue.

Serious adverse reactions

Here are the serious side effects of Tagrisso:

• interstitial lung disease (ILD)/pneumonitis
• pneumonia
• heart rate disturbances (QTc Interval Prolongation)
• cardiomyopathy
• keratitis (inflammation of the cornea of the eye).

Use in a specific population

Tagrisso can be dangerous for a fetus. It’s best to avoid pregnancy during treatment and for 6 weeks after stopping. Men should use effective birth control for 4 months after their last dose. Also, do not breastfeed while taking Tagrisso.

Buy Rydapt (midostaurin)